BioHealth News Archive
Sands Capital Closes $560 Million Life Sciences Fund
ARLINGTON, Va., Aug. 9, 2021 /PRNewswire/ -- Sands Capital held a first and final closing of its second life sciences dedicated fund, Sands Capital Life…
Read MoreReverse BioTalk – Jeff Galvin, CEO of American Gene Technologies Interviews Rich Bendis, CEO and President of BioHealth Innovation, Inc.
Jeff Galvin, CEO of American Gene Technologies and Rich Bendis, CEO and President of BioHealth Innovation, Inc. have a fireside chat about the rapid…
Read MoreLicense with Sana Biotechnology | MaxCyte Inc
GAITHERSBURG, MD, 9 August 2021 - MaxCyte, Inc. (Nasdaq: MXCT) (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today announced the signing of…
Read MoreAdvanced Studies in Technology Transfer | Course Catalog and Student Handbook 2021-2022
The FAES Academic Programs at NIH offers a unique Advanced Studies in Technology Transfer to persons with a Bachelor’s degree in science or engineering…
Read MorePaul Rennie OBE and Professor Jason Snape Join Rich Bendis on BioTalk (2)
Paul Rennie OBE, Counsellor for Global Issues in the Global Economy Group at the British Embassy, Washington DC, and Professor Jason Snape, Head of…
Read MoreBHI EIR Feedback Day August 18th. Register Now! (2)
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read More8 hospitals, health systems piloting digital transformation programs
Hospitals and health systems across the U.S. are pushing forward digital transformation efforts by creating new tools and launching innovative programs. Here are the…
Read MoreIs Maryland Becoming a Hub for Bacteriophage Technologies? · BioBuzz
The Bacteriophage (Phage) Therapy (PT) market is growing rapidly in the U.S. The rise of antibiotic resistant bacteria and multidrug-resistant bacteria (MDRs) across the…
Read MoreGlycoMimetics Names Harout Semerjian as New Chief Executive Officer to Succeed Retiring CEO Rachel King – GlycoMimetics, Inc.
ROCKVILLE, Md.--(BUSINESS WIRE)--Aug. 4, 2021-- GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that its Board of Directors has appointed Harout Semerjian as chief executive officer…
Read MorePharmaceutical industry must fix broken supply chain: Phlow
A leader from the company says to ensure medicines keep reaching the patients that need them, the industry must revamp outdated technologies and techniques.…
Read MoreEY named founding member of the University of Maryland Quantum Startup Foundry
COLLEGE PARK, Md. – The Quantum Startup Foundry (QSF) at the University of Maryland (UMD) today announced that Ernst & Young LLP (EY US)…
Read MoreAstraZeneca chief calls for global cooperation in the fight against COVID-19 and climate change – I by IMD
The chief executive of AstraZeneca has underscored the importance of multilateral cooperation in the fight against COVID-19 as well as other systemic global challenges…
Read MorePaul Rennie OBE and Professor Jason Snape Join Rich Bendis on BioTalk
Paul Rennie OBE, Counsellor for Global Issues in the Global Economy Group at the British Embassy, Washington DC, and Professor Jason Snape, Head of…
Read MoreBHI EIR Feedback Day August 18th. Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreMaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market
GAITHERSBURG, Md., July 29, 2021 /PRNewswire/ -- MaxCyte, Inc., (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today announced the pricing of…
Read More